Objective: To evaluate the association of the PTPN2 rs1893217 polymorphism with T1DM and/or its clinical and laboratory characteristics in a Caucasian population from Southern Brazil.
Subjects And Methods: Four hundred and eighty six patients with T1DM and 484 non-diabetic subjects were included in the study. Genotyping of the PTPN2 rs1893217 was performed by real-time PCR.
Results: Genotype frequencies did not differ between T1DM patients and non-diabetic subjects (P = 0.265). The C allele was observed in 14.5% of the T1DM sample and 12.2% of the non-diabetic group (P = 0.152). Moreover, the frequencies of this variant did not differ statistically between T1DM patients and non-diabetic subjects when assuming recessive, dominant, or additive inheritance models. The clinical and laboratory characteristics of T1DM patients did not differ significantly among the three genotypes of the rs1893217 polymorphism, either.
Conclusion: The PTPN2 rs1893217 polymorphism is not significantly associated with T1DM in Caucasian subjects from Southern Brazil.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1590/0004-2730000003050 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tofacitinib Mitigates the Increased SARS-CoV-2 Infection Susceptibility Caused by an IBD Risk Variant in the PTPN2 Gene.
Cell Mol Gastroenterol Hepatol
January 2025
Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, California, USA. Electronic address:
Background: Coronavirus disease (COVID-19), caused by SARS-CoV-2, triggered a global pandemic with severe medical and socioeconomic consequences. While fatality rates are higher among the elderly and those with underlying comorbidities, host factors that promote susceptibility to SARS-CoV-2 infection and severe disease are poorly understood. Although individuals with certain autoimmune/inflammatory disorders show increased susceptibility to viral infections, there is incomplete knowledge of SARS-CoV-2 susceptibility in these diseases.
View Article and Find Full Text PDFThe JAK inhibitor, Tofacitinib, Corrects the Overexpression of CEACAM6 and Limits Susceptibility to AIEC Caused by Reduced Activity of the IBD Associated Gene, .
medRxiv
September 2024
Division of Biomedical Sciences, University of California, Riverside, Riverside, California.
Article Synopsis
- - A subset of patients with inflammatory bowel disease (IBD) shows an increase in a harmful gut bacteria known as adherent-invasive E. coli (AIEC), which is connected to mutations in the protein tyrosine phosphatase type 2 (PTPN2) gene that disrupts gut microbiota balance.
- - The study examines how the host protein CEACAM6, which AIEC uses to invade intestinal cells, is regulated in the context of the PTPN2 gene and its variants, finding that patients with specific SNPs have higher CEACAM6 levels.
- - Experimental cell lines with altered PTPN2 expression showed increased adhesion and invasion by AIEC, indicating that the absence of PTP
T cell protein tyrosine phosphatase protects intestinal barrier function by restricting epithelial tight junction remodeling.
J Clin Invest
September 2021
Division of Biomedical Sciences, School of Medicine, University of California, Riverside, Riverside, California, USA.
Genome-wide association studies revealed that loss-of-function mutations in protein tyrosine phosphatase non-receptor type 2 (PTPN2) increase the risk of developing chronic immune diseases, such as inflammatory bowel disease (IBD) and celiac disease. These conditions are associated with increased intestinal permeability as an early etiological event. The aim of this study was to examine the consequences of deficient activity of the PTPN2 gene product, T cell protein tyrosine phosphatase (TCPTP), on intestinal barrier function and tight junction organization in vivo and in vitro.
View Article and Find Full Text PDFModulation of the Mucosa-Associated Microbiome Linked to the PTPN2 Risk Gene in Patients with Primary Sclerosing Cholangitis and Ulcerative Colitis.
Microorganisms
August 2021
Department of Gastroenterology and Hepatology, University Hospital Zurich, Rämistrasse 100, 8091 Zürich, Switzerland.
Gut microbiota appears to be involved in the pathogenesis of primary sclerosing cholangitis (PSC). The protein tyrosine phosphatase nonreceptor 2 (PTPN2) gene risk variant rs1893217 is associated with gut dysbiosis in inflammatory bowel disease (IBD), and PTPN2 was mentioned as a possible risk gene for PSC. This study assessed the microbial profile of ulcerative colitis (UC) patients with PSC and without PSC (non-PSC).
View Article and Find Full Text PDFIdentification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse Cells.
bioRxiv
December 2020
Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, California, USA.
Article Synopsis
- - COVID-19, caused by the SARS-CoV-2 virus, has led to over 65 million infections and 1.5 million deaths, with higher fatality rates in older individuals and those with pre-existing health conditions.
- - Research indicates that the genetic variant rs1893217, associated with autoimmune disorders, increases the expression of the ACE2 receptor, enhancing the virus's ability to enter cells.
- - The study highlights that the increased ACE2 expression and virus entry, driven by JAK-STAT signaling, can be counteracted by the JAK inhibitor tofacitinib, providing a potential therapeutic avenue.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!